A randomized, double-blind, multicentre, parallel, placebo-controlled Phase 2b study in subjects with idiopathic pulmonary fibrosis (IPF) investigating the efficacy and safety of TD139, an inhaled galectin-3 inhibitor administered via a dry powder in

Project Details

StatusActive
Effective start/end date1/02/211/02/23

Funding

  • INCResearch Pty Ltd: AUD19,362.00
  • INCResearch Pty Ltd: AUD19,362.00
  • INCResearch Pty Ltd: AUD19,362.00